During these challenging and turbulent days, AryoGen Pharmed, with the dedicated presence of its employees and specialists, along with their continuous efforts and spirit of commitment, has successfully advanced the production of the vital medicine Rheuflix (Infliximab) to the packaging stage for distribution in the domestic market. This achievement will enable the targeted patient community to benefit from this important therapeutic product.

Indications of Rheuflix

In adults, Rheuflix is used for the treatment of the following inflammatory conditions:

* Rheumatoid arthritis
* Psoriatic arthritis
* Ankylosing spondylitis (Bechterew’s disease)
* Psoriasis

Rheuflix is also used in both adults and children for the treatment of:

* Crohn’s disease
* Ulcerative colitis

Additionally, based on a physician’s assessment, this medicine may be prescribed for the following indications:

**Adults:**

* Hospitalized patients with COVID-19
* Pustular psoriasis
* Refractory sarcoidosis
* Immune checkpoint inhibitor-induced colitis

**Children:**

* Juvenile idiopathic arthritis refractory to conventional therapies
* Kawasaki disease resistant to IVIG treatment
* SARS-CoV-2-related multisystem inflammatory syndrome (MIS-C)

**AryoGen Pharmed** remains committed to advancing access to essential medicines through innovation, expertise, and the dedication of its employees, contributing to improved healthcare outcomes for patient